HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hoshi, H. Articles by Wakisaka, S. Search for Related Content PubMed PubMed Citation Articles by Hoshi, H. Articles by Wakisaka, S.

Cerebral Blood Flow Study in Patients with Moyamoya Disease Evaluated by IMP SPECT

Department of Radiology and Department of Neurosurgery, Miyazaki Medical College, Miyazaki, Japan

Correspondence: For correspondence and reprints contact: Hiroaki Hoshi, MD, Dept. of Radiology, Miyazaki Medical College, Miyazaki, 88916, Japan.

ABSTRACT

We studied the usefulness of IMP SPECT with acetazolamide in 16 patients with moyamoya disease. Cerebral angiography was performed for all patients who were classified in three grades according to their angiographic stages. Methods: Techniques used included ring-type emission computed tomography with a minicomputer system. Patients received 111 MBq of ¹²³I-IMP and SPECT images were obtained 20 min postinjection. Nine patients were studied using iodoamphetamine (IMP) SPECT with and without acetazolamide. IMP SPECT with acetazolamide was performed 20 min after each injection of 1 g of acetazolamide. Results: Low perfusion areas in the upper and lower frontal, parietal and temporal regions in grades 2 and 3 using IMP SPECT were observed. The mean cerebral-to-cerebellar activity ratios (C/C ratio) of six regions (upper and lower frontal, temporal, parietal occipital and basal ganglia) in grades 1, 2 and 3 were 0.96 to 1.06, 0.91 to 0.96 and 0.76 to 0.88, respectively. Conclusion: Our results indicate that measurement of regional cerebral blood flow (rCBF) elucidates cerebral hemodynamic factors, including the reactivity of cerebral vessels which cannot be detected angiographically in patients with moyamoya disease, and that the acetazolamide test is useful for detecting cerebral blood flow reserve. The test can be used to detect disease progress prospectively.

Key Words: iodoamphetamine • moyamoya disease • cerebral blood flow

This article has been cited by other articles:

				K. Ogasawara, T. Okuguchi, M. Sasoh, M. Kobayashi, H. Yukawa, K. Terasaki, T. Inoue, and A. Ogawa Qualitative versus Quantitative Assessment of Cerebrovascular Reactivity to Acetazolamide Using iodine-123-N-Isopropyl-p-Iodoamphetamine SPECT in Patients with Unilateral Major Cerebral Artery Occlusive Disease AJNR Am. J. Neuroradiol., June 1, 2003; 24(6): 1090 - 1095. [Abstract] [Full Text] [PDF]

				A. Kassner, X.-P. Zhu, K.-L. Li, and A. Jackson Neoangiogenesis in Association with Moyamoya Syndrome Shown by Estimation of Relative Recirculation based on Dynamic Contrast-Enhanced MR Images AJNR Am. J. Neuroradiol., May 1, 2003; 24(5): 810 - 818. [Abstract] [Full Text] [PDF]

				K. Ogasawara, H. Ito, M. Sasoh, T. Okuguchi, M. Kobayashi, H. Yukawa, K. Terasaki, and A. Ogawa Quantitative Measurement of Regional Cerebrovascular Reactivity to Acetazolamide Using 123I-N-Isopropyl-p-Iodoamphetamine Autoradiography with SPECT: Validation Study Using H215O with PET J. Nucl. Med., April 1, 2003; 44(4): 520 - 525. [Abstract] [Full Text] [PDF]

				Y. Kuwabara, Y. Ichiya, M. Sasaki, T. Yoshida, K. Masuda, T. Matsushima, and M. Fukui Response to Hypercapnia in Moyamoya Disease : Cerebrovascular Response to Hypercapnia in Pediatric and Adult Patients With Moyamoya Disease Stroke, April 1, 1997; 28(4): 701 - 707. [Abstract] [Full Text]

				H. Touho, J. Karasawa, and H. Ohnishi Preoperative and Postoperative Evaluation of Cerebral Perfusion and Vasodilatory Capacity With 99mTc-HMPAO SPECT and Acetazolamide in Childhood Moyamoya Disease Stroke, February 1, 1996; 27(2): 282 - 289. [Abstract] [Full Text]